The funds will go towards scaling C2N Diagnostics’ laboratory services and advancing the company’s range of diagnostic tests.

Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), a multi-modal image database that aims to boost ...

The National Institute for Cancer Research and Treatment (NICRAT) in partnership with a Roche, multinational healthcare ...

This week the University of Liverpool launched the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), an ...

Basel: Roche has announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma.

The programme aims to enhance early detection and ensure timely, accurate breast cancer diagnosis by offering free immunohistochemistry tests, multidisciplinary care, and navigation services to 5,000 ...

Swiss pharma giant, Roche, in collaboration with Oncopadi Technologies, has launched a Breast Cancer Access Navigation and Testing Programme ...

A multinational healthcare company, Roche and a provider of digital integrated healthcare services, Oncopadi Technologies ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8513 ...

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...

Partnership includes the development of combination products, including a fixed-dose combination of petrelintide and Roche’s dual GLP-1/GIP receptor agonist, CT-388, for weight management.